FY2026 EPS Estimates for McKesson Cut by Leerink Partnrs

McKesson Co. (NYSE:MCK) – Research analysts at Leerink Partnrs lowered their FY2026 earnings estimates for shares of McKesson in a research report issued to clients and investors on Tuesday, May 27th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $37.43 per share for the year, down from their previous forecast of $37.73. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson’s Q4 2026 earnings at $11.17 EPS, FY2027 earnings at $42.37 EPS and FY2028 earnings at $48.06 EPS.

A number of other brokerages also recently weighed in on MCK. UBS Group raised their price objective on McKesson from $708.00 to $805.00 and gave the company a “buy” rating in a research note on Tuesday, April 29th. Wall Street Zen raised shares of McKesson from a “buy” rating to a “strong-buy” rating in a research report on Friday. Cfra Research cut shares of McKesson from a “moderate buy” rating to a “hold” rating in a research note on Friday, April 4th. Mizuho raised their target price on shares of McKesson from $630.00 to $690.00 and gave the company a “neutral” rating in a research note on Thursday, April 3rd. Finally, Morgan Stanley lifted their target price on shares of McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a report on Wednesday, April 2nd. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $686.69.

McKesson Price Performance

Shares of NYSE:MCK opened at $719.85 on Friday. The stock has a market capitalization of $90.06 billion, a P/E ratio of 32.96, a P/E/G ratio of 1.29 and a beta of 0.53. The business has a 50-day moving average of $695.18 and a two-hundred day moving average of $637.67. McKesson has a fifty-two week low of $464.42 and a fifty-two week high of $731.00.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.83 by $0.29. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The firm had revenue of $90.82 billion during the quarter, compared to analysts’ expectations of $94 billion. During the same period in the prior year, the company posted $6.18 earnings per share. McKesson’s revenue for the quarter was up 18.9% on a year-over-year basis.

Institutional Trading of McKesson

A number of institutional investors and hedge funds have recently modified their holdings of the company. T. Rowe Price Investment Management Inc. boosted its stake in McKesson by 8.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,847,385 shares of the company’s stock worth $1,622,754,000 after buying an additional 222,496 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of McKesson by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 2,663,303 shares of the company’s stock worth $1,513,195,000 after acquiring an additional 10,015 shares during the period. Franklin Resources Inc. boosted its position in shares of McKesson by 4.6% during the 4th quarter. Franklin Resources Inc. now owns 2,620,948 shares of the company’s stock valued at $1,493,704,000 after acquiring an additional 114,396 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of McKesson by 75,632.7% during the 1st quarter. GAMMA Investing LLC now owns 2,393,152 shares of the company’s stock valued at $1,610,567,000 after acquiring an additional 2,389,992 shares in the last quarter. Finally, Norges Bank bought a new stake in McKesson in the fourth quarter valued at about $1,200,361,000. 85.07% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Thomas L. Rodgers sold 510 shares of the stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $717.91, for a total value of $366,134.10. Following the completion of the sale, the executive vice president now owns 5,435 shares in the company, valued at approximately $3,901,840.85. This trade represents a 8.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the business’s stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $726.51, for a total value of $394,494.93. Following the transaction, the chief accounting officer now owns 1,972 shares in the company, valued at $1,432,677.72. This represents a 21.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,856 shares of company stock worth $7,793,675 in the last ninety days. Insiders own 0.11% of the company’s stock.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be given a $0.71 dividend. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $2.84 annualized dividend and a yield of 0.39%. McKesson’s dividend payout ratio is 10.99%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.